The Argus II retina prosthetic is primed for FDA approval. Neuromodulation has become a hot segment in the medtech industry. A Maryland teen patents his own medical device.
The First Bionic Eye May be Coming to the U.S.
The Argus II retinal prosthesis system, which is currently being evaluated in clinical studies in the U.S. And Europe, could receive FDA approval as soon as next week. The device is meant as a prosthetic to replace the retina in an otherwise healthy eye – allowing patients with retinitis pigmentosa, a degenerative disease of the retina that leads to vision loss and often blindness, to see clearly.
The Wall Street Journal reports on the Argus II:
Neuromodulation Among the Fastest Growing Medtech Segments
According to a recent study by Research and Markets, neuromodulation – devices that act directly on the activity of nerves in a target area – as emerged as one of the fastest growing segments of the medical device market due to high demand for minimally invasive and non–invasive treatment. The main drivers for the neuromodulation market are the rising population of aged people and age-related diseases like Alzheimer’s, epilepsy, spinal cord injury, and Parkinson’s disease. [Research and Markets]
Teen Patents Medical Device
Fifteen year old Jack Andraka of Maryland, winner of the 2012 Intel Science Fair has patented his award winning entry - a device to detect pancreatic cancer. [ WTOP ]